25 min
Exploring the Future of Clinical Trials pt. 2 feat. Bristol Myers Squibb's Marisa Co and Gaelan Ritter The ConcertAI Podcast
-
- Life Sciences
In this episode, we continue to discuss the historic challenges of running clinical trials in community settings and how AI-powered patient identification tools and semi-automated data solutions are changing the game.
Bristol Myers Squibb's Marisa and Gaelan share how their collaboration with ConcertAI on the Digitally Accelerated Clinical Trial Solution (DACT) is lowering the burden on patients and sites, and increasing the number of clinical trial types that can be run in community settings. The platform not only meets FDA imperatives but also makes much-needed medicines available to a wider array of patients.
Join us as we dive deep into the exciting developments in clinical research and discover how technology is improving patient outcomes.
Website
www.ConcertAI.com
LinkedIn
www.linkedin.com/company/concertai/
Twitter
www.twitter.com/concertai
In this episode, we continue to discuss the historic challenges of running clinical trials in community settings and how AI-powered patient identification tools and semi-automated data solutions are changing the game.
Bristol Myers Squibb's Marisa and Gaelan share how their collaboration with ConcertAI on the Digitally Accelerated Clinical Trial Solution (DACT) is lowering the burden on patients and sites, and increasing the number of clinical trial types that can be run in community settings. The platform not only meets FDA imperatives but also makes much-needed medicines available to a wider array of patients.
Join us as we dive deep into the exciting developments in clinical research and discover how technology is improving patient outcomes.
Website
www.ConcertAI.com
LinkedIn
www.linkedin.com/company/concertai/
Twitter
www.twitter.com/concertai
25 min